Search for other papers by Avinaash Maharaj in
Google Scholar
PubMed
Search for other papers by Ruth Kwong in
Google Scholar
PubMed
Search for other papers by Jack Williams in
Google Scholar
PubMed
Search for other papers by Christopher Smith in
Google Scholar
PubMed
Search for other papers by Helen Storr in
Google Scholar
PubMed
Search for other papers by Ruth Krone in
Google Scholar
PubMed
Search for other papers by Debora Braslavsky in
Google Scholar
PubMed
Search for other papers by Maria Clemente in
Google Scholar
PubMed
Search for other papers by Nanik Ram in
Google Scholar
PubMed
Search for other papers by Indraneel Banerjee in
Google Scholar
PubMed
Search for other papers by Semra Çetinkaya in
Google Scholar
PubMed
Search for other papers by Federica Buonocore in
Google Scholar
PubMed
Search for other papers by Tülay Güran in
Google Scholar
PubMed
Search for other papers by John C Achermann in
Google Scholar
PubMed
Search for other papers by Louise Metherell in
Google Scholar
PubMed
Search for other papers by Rathi Prasad in
Google Scholar
PubMed
Introduction Sphingosine-1-phosphate lyase insufficiency syndrome (SPLIS; nephrotic syndrome, type 14; NPHS14; MIM 617575), a multi-systemic disorder of sphingolipid metabolism first described in 2017, is caused by variants in SGPL1 , in
Department of Electronic Science, State Key Laboratory of Physical Chemistry of Solid Surfaces, Xiamen University, Xiamen, China
Search for other papers by Jia Li in
Google Scholar
PubMed
Search for other papers by Yan Zhao in
Google Scholar
PubMed
Search for other papers by Caoxin Huang in
Google Scholar
PubMed
Search for other papers by Zheng Chen in
Google Scholar
PubMed
Search for other papers by Xiulin Shi in
Google Scholar
PubMed
Search for other papers by Long Li in
Google Scholar
PubMed
Search for other papers by Zhong Chen in
Google Scholar
PubMed
Search for other papers by Xuejun Li in
Google Scholar
PubMed
the histological NAFLD severity ( 13 ). Moreover, plasma lipids, such as diacylglycerol, triacylglycerol, cholesteryl ester, sphingolipid and glycerophospholipid, can distinguish NASH (non-alcoholic steatohepatitis) from steatosis ( 14 ). Our
Clinical Research Center for Metabolic Disease, Gansu Province, Lanzhou, Gansu, China
The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Feifei Shao in
Google Scholar
PubMed
The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Xinxin Hu in
Google Scholar
PubMed
The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Jiayu Li in
Google Scholar
PubMed
The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Bona Bai in
Google Scholar
PubMed
Clinical Research Center for Metabolic Disease, Gansu Province, Lanzhou, Gansu, China
The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China
Search for other papers by Limin Tian in
Google Scholar
PubMed
observed to lead to increased levels of long-chain acyl-carnitines, and several lipids have been selected as biomarkers of aging, especially sphingolipids, ether-linked phospholipids, and ester-linked phospholipids ( 12 , 13 , 14 ). It seems complex and
Search for other papers by Mohamed Asrih in
Google Scholar
PubMed
Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Flore Sinturel in
Google Scholar
PubMed
Search for other papers by Richard Dubos in
Google Scholar
PubMed
Search for other papers by Idris Guessous in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Zoltan Pataky in
Google Scholar
PubMed
Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Charna Dibner in
Google Scholar
PubMed
Department of Cell Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Vandereycken B Saini C Gosselin P Brulhart-Meynet MC Robert M Chanon S , Ether lipids, sphingolipids and toxic 1-Deoxyceramides as hallmarks for lean and obese Type 2 diabetic patients . Acta Physiologica 2021 232 e13610. ( https://doi.org/10
Search for other papers by Tao Gao in
Google Scholar
PubMed
Search for other papers by Rui Liu in
Google Scholar
PubMed
Search for other papers by Chunli Li in
Google Scholar
PubMed
Search for other papers by Xinglin Chu in
Google Scholar
PubMed
Search for other papers by Qiao Guo in
Google Scholar
PubMed
Search for other papers by Dazhi Ke in
Google Scholar
PubMed
involved in complement and coagulation cascade reaction, platelet activation, histidine metabolism, vitamin metabolism and absorption, fat digestion and absorption, sphingolipid metabolism, cholesterol metabolism, and other pathways ( Fig. 2 ). Basic
Search for other papers by Yu Lin in
Google Scholar
PubMed
Search for other papers by Yingying Zhang in
Google Scholar
PubMed
Search for other papers by Lei Xu in
Google Scholar
PubMed
Search for other papers by Wei Long in
Google Scholar
PubMed
Search for other papers by Chunjian Shan in
Google Scholar
PubMed
Search for other papers by Hongjuan Ding in
Google Scholar
PubMed
Search for other papers by Lianghui You in
Google Scholar
PubMed
Search for other papers by Chun Zhao in
Google Scholar
PubMed
Search for other papers by Zhonghua Shi in
Google Scholar
PubMed
genes were found to be involved in cytokine–cytokine receptor interaction, sphingolipid metabolism, NOD-like receptor signaling pathway, etc. Interestingly, 583 down-regulated genes were found to be involved in metabolic pathways, insulin signaling
Search for other papers by Stephen A Martin in
Google Scholar
PubMed
Search for other papers by Kenneth A Philbrick in
Google Scholar
PubMed
Search for other papers by Carmen P Wong in
Google Scholar
PubMed
Search for other papers by Dawn A Olson in
Google Scholar
PubMed
Search for other papers by Adam J Branscum in
Google Scholar
PubMed
Search for other papers by Donald B Jump in
Google Scholar
PubMed
Search for other papers by Charles K Marik in
Google Scholar
PubMed
Search for other papers by Jonathan M DenHerder in
Google Scholar
PubMed
Search for other papers by Jennifer L Sargent in
Google Scholar
PubMed
Center for Healthy Aging Research, Oregon State University, Corvallis, Oregon, USA
Search for other papers by Russell T Turner in
Google Scholar
PubMed
Center for Healthy Aging Research, Oregon State University, Corvallis, Oregon, USA
Search for other papers by Urszula T Iwaniec in
Google Scholar
PubMed
types or regions (e.g., proximal, midshaft, distal); additionally, our methodology does not allow us to distinguish between lipid classes (e.g., non-esterified fatty acids, glycerolipids, sphingolipids, ether lipids, or waxes). The 16-week-old male B6
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
models highlights changes in sphingolipid metabolism . Scientific Reports 2019 9 16810 . ( https://doi.org/10.1038/s41598-019-53346-4 ) 27 Parthasarathy G Revelo X Malhi H Pathogenesis of nonalcoholic steatohepatitis: an overview
Search for other papers by Alice Costantini in
Google Scholar
PubMed
Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland
Search for other papers by Mari H Muurinen in
Google Scholar
PubMed
Folkhälsan Institute of Genetics, University of Helsinki, Helsinki, Finland
Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Outi Mäkitie in
Google Scholar
PubMed
sphingomyelin synthase 2 cause SMD Sphingomyelin is a sphingolipid of the plasma membrane and the Golgi membranes. Monoallelic pathogenic variants in the gene encoding sphingomyelin synthase 2 ( SGMS2 ), an enzyme that catalyzes the synthesis of sphingomyelin